Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection
Erector Spinae Plane Block Catheters: The Role in Acute Postoperative Pain After Hepatic Resection With Intrathecal Morphine
University of California, San Diego
70 participants
May 24, 2021
INTERVENTIONAL
Conditions
Summary
To determine whether the addition of erector spinae plane (ESP) catheters to existing multimodal analgesic regimen with intrathecal morphine provides superior postoperative analgesia in patients undergoing hepatic resection compared with patients not receiving ESP catheters.
Eligibility
Inclusion Criteria3
- undergoing hepatic resection
- Admitting service requests APS consult
- >18 years old and able to provide consent
Exclusion Criteria7
- pregnancy
- incarceration
- inability to communicate with the investigators and hospital staff
- severe hepatic disease
- chronic high-dose opioid use (defined as daily use for more than 4 weeks prior to surgery of at least the equivalent of 20 mg oxycodone);
- BMI > 40 kg/m2
- allergy to study medications (lidocaine, ropivacaine)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Treatment- continuous erector spinae block catheter followed by an infusion of ropivacaine 0.2% at 10ml automatic set bolus per 60 minute with 2ml/hr continuous infusion (12mls/hr total per catheter)
Placebo- Superficially placed (taped to the surface) erector spinae block catheter with a ropivacaine 0.2% infusion at 0.1ml /hr
200-300 mcg of spinal morphine
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04849455